KYLE PISKEL, the Chief Financial Officer of $ADPT, sold 162,820 shares of the company on 11-28-2025 for an estimated $3,174,990. We received data on the trade from a recent SEC filing. This was a sale of approximately 42.9% of their shares of this class of stock. Following this trade, they now own 216,637 shares of this class of $ADPT stock.
$ADPT Insider Trading Activity
$ADPT insiders have traded $ADPT stock on the open market 10 times in the past 6 months. Of those trades, 0 have been purchases and 10 have been sales.
Here’s a breakdown of recent trading of $ADPT stock by insiders over the last 6 months:
- SHARON BENZENO (Chief Commercial Ofc Imm Med) has made 0 purchases and 2 sales selling 606,402 shares for an estimated $10,144,025.
- CHAD M ROBINS (CEO and Chairman) has made 0 purchases and 5 sales selling 249,999 shares for an estimated $4,385,926.
- KYLE PISKEL (Chief Financial Officer) has made 0 purchases and 2 sales selling 163,058 shares for an estimated $3,178,333.
- HARLAN S ROBINS (Chief Scientific Officer) sold 10,000 shares for an estimated $148,200
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$ADPT Hedge Fund Activity
We have seen 145 institutional investors add shares of $ADPT stock to their portfolio, and 129 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- RUBRIC CAPITAL MANAGEMENT LP removed 6,256,847 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $93,602,431
- BRAIDWELL LP removed 3,127,093 shares (-80.9%) from their portfolio in Q3 2025, for an estimated $46,781,311
- AMERIPRISE FINANCIAL INC added 2,731,648 shares (+84.3%) to their portfolio in Q3 2025, for an estimated $40,865,454
- ARROWSTREET CAPITAL, LIMITED PARTNERSHIP added 2,062,282 shares (+544.0%) to their portfolio in Q3 2025, for an estimated $30,851,738
- NIKKO ASSET MANAGEMENT AMERICAS, INC. removed 1,786,006 shares (-29.3%) from their portfolio in Q2 2025, for an estimated $20,806,969
- DEUTSCHE BANK AG\ added 1,542,685 shares (+905.0%) to their portfolio in Q3 2025, for an estimated $23,078,567
- MACQUARIE GROUP LTD added 1,444,358 shares (+218.8%) to their portfolio in Q3 2025, for an estimated $21,607,595
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$ADPT Revenue
$ADPT had revenues of $94M in Q3 2025. This is an increase of 102.38% from the same period in the prior year.
You can track ADPT financials on Quiver Quantitative's ADPT stock page.
$ADPT Analyst Ratings
Wall Street analysts have issued reports on $ADPT in the last several months. We have seen 6 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- JP Morgan issued a "Overweight" rating on 11/06/2025
- BTIG issued a "Buy" rating on 11/06/2025
- Piper Sandler issued a "Overweight" rating on 10/15/2025
- Guggenheim issued a "Buy" rating on 09/30/2025
- TD Cowen issued a "Buy" rating on 08/06/2025
- Craig-Hallum issued a "Buy" rating on 06/18/2025
To track analyst ratings and price targets for $ADPT, check out Quiver Quantitative's $ADPT forecast page.
$ADPT Price Targets
Multiple analysts have issued price targets for $ADPT recently. We have seen 8 analysts offer price targets for $ADPT in the last 6 months, with a median target of $18.5.
Here are some recent targets:
- Tejas Savant from Morgan Stanley set a target price of $16.0 on 11/11/2025
- Rachel Vatnsdal from JP Morgan set a target price of $20.0 on 11/06/2025
- Mark Massaro from BTIG set a target price of $21.0 on 11/06/2025
- David Westenberg from Piper Sandler set a target price of $20.0 on 10/15/2025
- Subbu Nambi from Guggenheim set a target price of $20.0 on 09/30/2025
- Dan Brennan from TD Cowen set a target price of $15.0 on 08/06/2025
- John Wilkin from Craig-Hallum set a target price of $15.0 on 06/18/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
